Shelley McClure
Endocrinology, Diabetes & Metabolism · Norman, OKNPI 1184392649
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.4% of the total across 107 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 18.4% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for endocrinology, diabetes & metabolism clinicians in OK, where the typical reported total is $2,620.
Across 107 payments — averaging $24.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Corcept Therapeutics$483
- Sanofi-aventis U.S. LLC$335
- Bayer$285
- Dexcom, Inc.$244
- Xeris Pharmaceuticals, Inc.$198
- Boehringer Ingelheim$192
- plus $883 from 18 others
What the payments were for
- Food & beverage$2,57898%
- Education$432%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Corcept Therapeutics | 15 | $483 |
| Sanofi-aventis U.S. LLC | 14 | $335 |
| Bayer | 9 | $285 |
| Dexcom, Inc. | 10 | $244 |
| Xeris Pharmaceuticals, Inc. | 13 | $198 |
| Boehringer Ingelheim | 11 | $192 |
| Lilly USA, LLC | 9 | $163 |
| AstraZeneca(2 entities) | 2 | $145 |
| Daiichi Sankyo Inc. | 1 | $122 |
| Mannkind Corporation | 2 | $70 |
| Madrigal Pharmaceuticals | 3 | $70 |
| Novo Nordisk | 4 | $68 |
| Antares Pharma, Inc. | 2 | $35 |
| Medtronic | 2 | $31 |
| Echosens North America, Inc. | 1 | $25 |
| AbbVie | 1 | $22 |
| Johnson & Johnson | 1 | $21 |
| Rhythm Pharmaceuticals, Inc. | 1 | $19 |
| Amneal Pharmaceuticals LLC | 1 | $19 |
| Ascensia Diabetes Care US Inc. | 1 | $16 |
| Tandem Diabetes Care, Inc. | 1 | $16 |
| Ultragenyx Pharmaceutical Inc. | 1 | $15 |
| Radius Health, Inc. | 1 | $15 |
| Merck | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$125
- SOLIQUA 100/33$124
- INJECTAFER$122
- Kerendia$120
- Korlym$108
How this compares
$2,620 in reported general payments places this provider in the 50th percentile of 61 endocrinology, diabetes & metabolism providers in Oklahoma.
See all endocrinology, diabetes & metabolism providers in Oklahoma →
Other endocrinology, diabetes & metabolism in Norman
- Lubna MirzaNorman$12K
- Tan PhamNorman$7K
- Cassie SmithEdmond$629K
- Cristin BrunsTulsa$159K
- Donald AspensonTulsa$153K
- Matthew DraelosEdmond$110K
- Christian MangrumOklahoma City$54K
- Vaqar AhmadMidwest City$27K
- Hanna FoggTulsa$25K
- Mario Bustos RodriguezTulsa$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.